China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

Market Cap	17.92B -4.3%
Revenue (ttm)	10.73B -3.7%
Net Income	1.63B +0.2%
EPS	1.57 -0.4%
Shares Out	1.03B
PE Ratio	11.06
Forward PE	10.24
Dividend	0.48 (2.77%)
Ex-Dividend Date	n/a

Volume	3,076,552
Average Volume	6,161,225
Open	17.35
Previous Close	17.35
Day's Range	17.11 - 17.35
52-Week Range	17.13 - 22.14
Beta	-0.00
RSI	28.23
Earnings Date	Apr 25, 2026

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure and sugar, injections, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, inflammation, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiar...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 13,184
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2025, SHA:600062's revenue was 11.00 billion, a decrease of -1.88% compared to the previous year's 11.21 billion. Earnings were 1.65 billion, an increase of 1.18%.